Congress Asset Management Co. MA raised its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) by 12.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 764,013 shares of the company’s stock after purchasing an additional 84,757 shares during the period. Congress Asset Management Co. MA owned 1.54% of Prestige Consumer Healthcare worth $55,437,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of PBH. Deutsche Bank AG grew its holdings in Prestige Consumer Healthcare by 21.1% during the third quarter. Deutsche Bank AG now owns 27,940 shares of the company’s stock valued at $1,598,000 after purchasing an additional 4,867 shares during the period. Rhumbline Advisers grew its position in shares of Prestige Consumer Healthcare by 1.1% in the third quarter. Rhumbline Advisers now owns 173,818 shares of the company’s stock valued at $9,941,000 after purchasing an additional 1,951 shares in the last quarter. QRG Capital Management Inc. purchased a new position in shares of Prestige Consumer Healthcare in the third quarter valued at $306,000. Provence Wealth Management Group purchased a new position in shares of Prestige Consumer Healthcare in the third quarter valued at $26,000. Finally, Hsbc Holdings PLC grew its position in shares of Prestige Consumer Healthcare by 17.1% in the third quarter. Hsbc Holdings PLC now owns 22,075 shares of the company’s stock valued at $1,263,000 after purchasing an additional 3,226 shares in the last quarter. 99.95% of the stock is owned by institutional investors.
Prestige Consumer Healthcare Price Performance
Prestige Consumer Healthcare stock traded up $4.12 during midday trading on Friday, hitting $69.40. 801,810 shares of the company’s stock were exchanged, compared to its average volume of 211,611. Prestige Consumer Healthcare Inc. has a 52-week low of $56.34 and a 52-week high of $75.31. The stock has a 50-day moving average price of $67.16 and a two-hundred day moving average price of $66.34. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 3.20. The company has a market cap of $3.46 billion, a P/E ratio of 16.64, a PEG ratio of 1.85 and a beta of 0.50.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on PBH. StockNews.com cut Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. DA Davidson upgraded Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and lifted their price target for the company from $65.00 to $93.00 in a research report on Friday. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $80.00 price target on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $98.25.
Check Out Our Latest Research Report on Prestige Consumer Healthcare
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Featured Articles
- Five stocks we like better than Prestige Consumer Healthcare
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- McDonald’s Stock: Balancing Value and Innovation
- Quiet Period Expirations Explained
- MarketBeat Week in Review – 6/17 – 6/21
- What is the S&P/TSX Index?
- Sarepta Therapeutics Stock Soars on FDA Approval
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.